Global Rare Biomarkers Specimen Collection & Stabilization Market (2020-2025) by Product, Type, Application, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Rare Biomarkers Specimen Collection & Stabilization Market is estimated to be USD 25.69 Bn in 2020 and is expected to reach USD 43.68 Bn by 2025, growing at a CAGR of 11.2%.

Market Dynamics

The market is driven by technological advancements in biomarker isolation, expanding applications of rare biomarkers specimen, growing awareness about early and rapid cancer diagnosis, etc.

The market growth is hindered by technical challenges in biomarker isolation and challenges associated with clinical implementation.

Growth in government and non-government initiatives for exosome research have created growth opportunities.

Market Segmentation

The Global Rare Biomarkers Specimen Collection & Stabilization Market is segmented further based on Product, Type, Application, End user and Geography.

By Product, the market is classified into Isolation Kits & Reagents, Blood Collection Tubes and Systems.

By Type, the market is classified into Circulating Call Free DNA (ccfDNA), Circulating Tumour Cells (CTCs) and Exosomes/Extracellular Vesicles.

By Application, the market is classified into NIPT, Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases and Others.

By End User, the market is classified amongst Hospitals & Healthcare Providers, Research Institute, Biotechnology Companies and others.

By Geography, North America is projected to lead the market.

Recent Developments
1. In April 2019, Macrogen and Exosome Plus signed a supply contract under which Macrogen would be the exclusive buyer of the exosome isolation kits developed by the latter company. Exosome Plus would supply its Exo2D to Macrogen for 1 year and Macrogen would sell the isolation kits to third parties.
2. Roche and Amgen, have collaborated with companies offering liquid biopsy for the development of companion diagnostics and accelerate the personalized medicine approach.

Company Profiles

Some of the companies covered in this report are Agena Bioscience, BioChain Institute, Inc., Epic Sciences, Biovision Inc., Geno Technology Inc., Roche, ANGLE plc., Biolidics Limited, Biomatrica Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc etc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Rare Biomarkers Specimen Collection & Stabilization Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market